Ask AI
Benjamin Levy

Benjamin Levy, MD, FASCO

Associate Professor

Johns Hopkins School of Medicine

Baltimore, Maryland, United States of America

Associate Professor, John Hopkins School of Medicine
Clinical Director, John Hopkins Sidney Kimmel Cancer Center,
National Capital Region (NCR)
Medical Director, Thoracic Medical Oncology NCR
Baltimore, Maryland

Explore Activities by Benjamin Levy

Title
Format
Credit Type
Credits
HER2-Positive NSCLC Treatment

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Analysis: Clinical Advances Journal Club on Emerging TROP-2 and TIGIT Therapies in Lung Cancer

Content Format:

Text Module

Credit Type:

AMA | EBAC®

Credits:

1.00
Emerging TROP-2 and TIGIT Therapies in Lung Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Exploring TROP2 and TIGIT Therapies in Lung Cancer: Lessons From Recent Trials and Looking Forward to New Horizons

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?

Content Format:

Podcast

Credit Type:

--

Credits:

--
Targeting TROP-2 and TIGIT: Novel Treatment Approaches for Lung Cancer in 2025

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Targeting TROP-2 and TIGIT: Experts Discuss How ADCs and Immunotherapeutic Combinations Are Transforming Lung Cancer Treatment

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Targeting TROP-2 and TIGIT: Experts Discuss How ADCs and Immunotherapeutic Combinations Are Transforming Lung Cancer Treatment

Content Format:

Slideset

Credit Type:

--

Credits:

--
Antibody‒Drug Conjugates Targeting TROP-2 in NSCLC: A Look to the Future

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Antibody‒Drug Conjugates Targeting TROP-2 in NSCLC: A Look to the Future

Content Format:

Slideset

Credit Type:

--

Credits:

--
Combination Therapy With TROP2-Targeted Antibody–Drug Conjugates and Immunotherapy in Advanced/Metastatic NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Role of Radiation Therapy in the Management of ES-SCLC

Content Format:

Video

Credit Type:

--

Credits:

--
Role of Radiation Therapy in the Management of ES-SCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?

Content Format:

Video

Credit Type:

--

Credits:

--
Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?

Content Format:

Slideset

Credit Type:

--

Credits:

--
Case Discussion: Newly Diagnosed ES-SCLC

Content Format:

Video

Credit Type:

--

Credits:

--
Case Discussion: Newly Diagnosed ES-SCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Overview of Therapeutic Options for Relapsed ES-SCLC

Content Format:

Video

Credit Type:

--

Credits:

--
Management of Limited-Stage SCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Overview of Therapeutic Options for Relapsed ES-SCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Management of Limited-Stage SCLC

Content Format:

Video

Credit Type:

--

Credits:

--